Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
29m
Oxford Medical Products touts positive safety data for ‘mechanical’ weight loss pill
The company is eyeing a pivotal trial for its dual-polymer hydrogel stomach implant following promising first-in-human trial ...
39m
NVO's Rybelsus Meets Primary Goal in MACE Study for Diabetes Patients
A late-stage study shows that Novo Nordisk's oral semaglutide, Rybelsus, cuts the risk of MACE by 14% in T2D patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Arrested in trafficking case
Sued by Murdoch’s firms
Target to cut prices
Splits with NY magazine
Arizona official pleads guilty
Chicago named 'rattiest city'
Crew ID’d in WA jet crash
Copyright infringement suit
AR marijuana votes blocked
1st trans lawyer at SCOTUS
FTC bans fake reviews
Meteorite aided early life?
Washington state shooting
US data protection move
Union opts out of CBA
Overseas ballot suits denied
Right whale population rises
Extends student loan pause
AU, US $4.7B missile deal
China holds live-fire drills
$400M aid package for UKR
Peru ex-president sentenced
Fuel pump concern recall
PA political threat case
Blinken arrives in Israel
Tests facial recognition tech
Infant mortality increased
Probing leak of US intel
Raises US growth forecast
Related topics
Europe
Rybelsus
Feedback